Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes

Molecular Therapy Methods and Clinical Development

Volumn 9, Issue , 2018, Pages 33-46

  Nass, Shelley A ^a   Mattingly, Maryellen A ^a   Woodcock, Denise A ^a   Burnham, Brenda L ^a   Ardinger, Jeffrey A ^a   Osmond, Shayla E ^a   Frederick, Amy M ^a   Scaria, Abraham ^a   Cheng, Seng H ^a   O'Riordan, Catherine R ^a  

^a SANOFI   (France)

Author keywords

AAV purification; analytical ultracentrifugation; epitope swapping

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS GENOME; VIRUS PURIFICATION;

EID: 85044852969     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1016/j.omtm.2017.12.004     Document Type: Article

References (26)

1. Ylä-Herttuala, S., Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol. Ther. 20 (2012), 1831–1832.
2. Hauswirth, W.W., Aleman, T.S., Kaushal, S., Cideciyan, A.V., Schwartz, S.B., Wang, L., Conlon, T.J., Boye, S.L., Flotte, T.R., Byrne, B.J., Jacobson, S.G., Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum. Gene Ther. 19 (2008), 979–990.
3. Maguire, A.M., Simonelli, F., Pierce, E.A., Pugh, E.N. Jr., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K.A., Testa, F., Surace, E.M., et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358 (2008), 2240–2248.
4. Maguire, A.M., High, K.A., Auricchio, A., Wright, J.F., Pierce, E.A., Testa, F., Mingozzi, F., Bennicelli, J.L., Ying, G.S., Rossi, S., et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374 (2009), 1597–1605.
5. Simonelli, F., Maguire, A.M., Testa, F., Pierce, E.A., Mingozzi, F., Bennicelli, J.L., Rossi, S., Marshall, K., Banfi, S., Surace, E.M., et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol. Ther. 18 (2010), 643–650.
6. Nathwani, A.C., Tuddenham, E.G., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D.C., Chowdary, P., Riddell, A., Pie, A.J., Harrington, C., et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365 (2011), 2357–2365.
7. Choudhury, S.R., Fitzpatrick, Z., Harris, A.F., Maitland, S.A., Ferreira, J.S., Zhang, Y., Ma, S., Sharma, R.B., Gray-Edwards, H.L., Johnson, J.A., et al. In vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy. Mol. Ther. 24 (2016), 1247–1257.
8. Grimm, D., Lee, J.S., Wang, L., Desai, T., Akache, B., Storm, T.A., Kay, M.A., In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J. Virol. 82 (2008), 5887–5911.
9. Ayuso, E., Mingozzi, F., Bosch, F., Production, purification and characterization of adeno-associated vectors. Curr. Gene Ther. 10 (2010), 423–436.
10. O'Riordan, C.R., Lachapelle, A.L., Vincent, K.A., Wadsworth, S.C., Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). J. Gene Med. 2 (2000), 444–454.
11. Zhou, J., Yang, X., Wright, J.F., High, K.A., Couto, L., Qu, G., PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9. J. Virol. Methods 173 (2011), 99–107.
12. Davidoff, A.M., Ng, C.Y., Sleep, S., Gray, J., Azam, S., Zhao, Y., McIntosh, J.H., Karimipoor, M., Nathwani, A.C., Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J. Virol. Methods 121 (2004), 209–215.
13. Mietzsch, M., Grasse, S., Zurawski, C., Weger, S., Bennett, A., Agbandje-McKenna, M., Muzyczka, N., Zolotukhin, S., Heilbronn, R., OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Hum. Gene Ther. 25 (2014), 212–222.
14. Oranje, P.P.A., Verheesen, P., Verbart, D., Mijnsbergen, Y., Haard, H.J.W., Hermans, P., et al. Isolation of an adeno-associated virus (AAV)-specific camelid-derived single chain antibody fragment: a novel tool for purification of AAV vectors of different serotypes. Mol. Ther., 9, 2004, S162.
15. Wang, Q., Lock, M., Prongay, A.J., Alvira, M.R., Petkov, B., Wilson, J.M., Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin. Mol. Ther. Methods Clin. Dev., 2, 2015, 15040.
16. Manno, C.S., Pierce, G.F., Arruda, V.R., Glader, B., Ragni, M., Rasko, J.J., Ozelo, M.C., Hoots, K., Blatt, P., Konkle, B., et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12 (2006), 342–347.
17. Qu, G., Bahr-Davidson, J., Prado, J., Tai, A., Cataniag, F., McDonnell, J., Zhou, J., Hauck, B., Luna, J., Sommer, J.M., et al. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography. J. Virol. Methods 140 (2007), 183–192.
18. Burnham, B., Nass, S., Kong, E., Mattingly, M., Woodcock, D., Song, A., Wadsworth, S., Cheng, S.H., Scaria, A., O'Riordan, C.R., Analytical ultracentrifugation as an approach to characterize recombinant adeno-associated viral vectors. Hum. Gene Ther. Methods 26 (2015), 228–242.
19. Khani, S.C., Pawlyk, B.S., Bulgakov, O.V., Kasperek, E., Young, J.E., Adamian, M., Sun, X., Smith, A.J., Ali, R.R., Li, T., AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest. Ophthalmol. Vis. Sci. 48 (2007), 3954–3961.
20. Halder, S., Van Vliet, K., Smith, J.K., Duong, T.T., McKenna, R., Wilson, J.M., Agbandje-McKenna, M., Structure of neurotropic adeno-associated virus AAVrh.8. J. Struct. Biol. 192 (2015), 21–36.
21. DiPrimio, N., Asokan, A., Govindasamy, L., Agbandje-McKenna, M., Samulski, R.J., Surface loop dynamics in adeno-associated virus capsid assembly. J. Virol. 82 (2008), 5178–5189.
22. King, J.A., Dubielzig, R., Grimm, D., Kleinschmidt, J.A., DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J. 20 (2001), 3282–3291.
23. Zolotukhin, S., Byrne, B.J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R.J., Muzyczka, N., Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6 (1999), 973–985.
24. Xiao, X., Li, J., Samulski, R.J., Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72 (1998), 2224–2232.
25. Thorne, B.A., Takeya, R.K., Peluso, R.W., Manufacturing recombinant adeno-associated viral vectors from producer cell clones. Hum. Gene Ther. 20 (2009), 707–714.
26. Martin, J., Frederick, A., Luo, Y., Jackson, R., Joubert, M., Sol, B., Poulin, F., Pastor, E., Armentano, D., Wadsworth, S., Vincent, K., Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production. Hum. Gene Ther. Methods 24 (2013), 253–269.